Investigation of the Effect of Remimazolam on Circulatory Management in Transurethral Resection of Bladder Tumor with 5-Aminolevulinic Acid
Not Applicable
- Conditions
- Muscle layer non-invasive bladder cancer
- Registration Number
- JPRN-UMIN000052910
- Lead Sponsor
- Chiba University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1) TUR-Bt patients who used anesthesia maintenance drugs other than sevoflurane and remimazolam 2) TUR-Bt patients who did not use PDD 3) Patients who expressed their refusal to participate in this study through the information disclosure document 4) Other cases deemed inappropriate by the investigator.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method